A randomized phase II study of pazopanib in castrate-sensitive prostate cancer: A University of Chicago phase II consortium/DoD Prostate Cancer Clinical Trials Consortium study.
James Edward Ward
No relevant relationships to disclose
Suwicha Limvorasak
No relevant relationships to disclose
Ted Karrison
No relevant relationships to disclose
Gurkamal S. Chatta
No relevant relationships to disclose
Maha Hussain
No relevant relationships to disclose
Daniel H. Shevrin
No relevant relationships to disclose
Russell Zelig Szmulewitz
No relevant relationships to disclose
Walter M. Stadler
No relevant relationships to disclose
Edwin M. Posadas
No relevant relationships to disclose